<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04384354</url>
  </required_header>
  <id_info>
    <org_study_id>DIGDMD</org_study_id>
    <nct_id>NCT04384354</nct_id>
  </id_info>
  <brief_title>Digestive Events in Duchenne Muscular Dystrophy Patients</brief_title>
  <acronym>DIGD</acronym>
  <official_title>Digestive Events in Duchenne Muscular Dystrophy Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d'Investigation Clinique et Technologique 805</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre d'Investigation Clinique et Technologique 805</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Relation between clinical and genetic features and acute digestive events in Duchenne
      muscular dystrophy patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical Data of the disease Digestive events (pseudo occlusion, gastrostomy,
      cholecystectomy) Nutritionnal parameters Genetic of dystrophin (approved genetic nationnal
      Data base, CHU Cochin, Paris France)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2007</start_date>
  <completion_date type="Actual">April 2019</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of digestive events</measure>
    <time_frame>11 years</time_frame>
    <description>Clinical parameters (yes or no): gastrostomy, bowel occlusion, acute gastric paresia, biliary complication</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of digestive events</measure>
    <time_frame>11 years</time_frame>
    <description>Clinical parameters (yes or no) : gastrostomy, bowel occlusion, acute gastric paresia, biliary complication</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Risk factors for digestive events (1)</measure>
    <time_frame>11 years</time_frame>
    <description>age (years)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Risk factors for digestive events (2)</measure>
    <time_frame>11 years</time_frame>
    <description>pulmonary functional tests (vital capacity in ml/kg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Risk factors for digestive events (3)</measure>
    <time_frame>11 years</time_frame>
    <description>echocardiography parameters (LVEF: left ventricular ejection fraction in %)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Risk factors for digestive events (4)</measure>
    <time_frame>11 years</time_frame>
    <description>residual dystrophin level (Western blot and/or immunohistochemistry in muscle)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Risks factors for digestive events (5)</measure>
    <time_frame>11 years</time_frame>
    <description>genetic parameters (type of mutation, functional domain of altered dystrophin)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nutritional status (1)</measure>
    <time_frame>11 years</time_frame>
    <description>Weigh (kg) and height (in m) agregated in BMI (kg/m^2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status (2)</measure>
    <time_frame>11 years</time_frame>
    <description>albuminemia in g/L</description>
  </secondary_outcome>
  <enrollment type="Actual">200</enrollment>
  <condition>Duchenne Muscular Dystrophy</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Duchenne muscular dystrophy patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all Duchenne muscular dystrophy patients in our center

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Only male patients, due to the specific disease (Duchenne muscular dystrophy patients)</gender_description>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>CICIT805 Garches</last_name>
    <role>Study Chair</role>
    <affiliation>APHP/UVSQ</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CICIT805</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>July 19, 2019</study_first_submitted>
  <study_first_submitted_qc>May 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2020</study_first_posted>
  <last_update_submitted>May 11, 2020</last_update_submitted>
  <last_update_submitted_qc>May 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre d'Investigation Clinique et Technologique 805</investigator_affiliation>
    <investigator_full_name>Crenn</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>pseudo occlusion</keyword>
  <keyword>gastrostomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Muscular Dystrophy, Duchenne</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>All clinician and biologist involved in the follow-up of these patients</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

